MOXILASE-DUO w/w Dry Syrup: Smart Pediatric Antibiotic Combination
Amoxycillin 400mg + Potassium Clavulanate 57mg Dry Syrup With Water & Monocarton
When a bacterial infection requires a combination antibiotic formulation, MOXILASE-DUO w/w Dry Syrup brings Amoxycillin 400mg + Potassium Clavulanate 57mg together in a convenient dry-syrup presentation. Its reconstitutable format is designed for oral administration when prescribed by a healthcare professional.
Packed in a 30 mL glass bottle with monocarton, MOXILASE-DUO offers a practical formulation for pediatric antibiotic therapy where this specific combination and strength are clinically appropriate.
Doctor's prescription matters: Antibiotics should be used only when recommended by a qualified healthcare professional.
💡 The Smart Combination Behind MOXILASE-DUO
Did you know? Amoxycillin + clavulanate combines an antibacterial agent with a beta-lactamase inhibitor. Clavulanate helps inhibit certain beta-lactamase enzymes that can otherwise reduce the activity of amoxycillin.
MOXILASE-DUO - INFORMATION
|
Product Detail |
Information |
|---|---|
|
Brand |
MOXILASE-DUO w/w DRY SYP |
|
Composition |
Amoxycillin 400mg + Potassium Clavulanate 57mg |
|
Dosage Form |
Dry Syrup |
|
Strength |
400mg + 57mg per 5 mL after reconstitution |
|
Pack Size |
30 mL |
|
Bottle |
Glass Bottle |
|
Packaging |
Monocarton |
|
MRP |
₹121.88 |
|
Route |
Oral |
Where Can MOXILASE-DUO Fit in Antibiotic Therapy?
MOXILASE-DUO may be prescribed for susceptible bacterial infections when an amoxicillin-clavulanate combination is considered appropriate.
-
Respiratory Infections – May be prescribed for selected susceptible bacterial respiratory infections.
-
Middle-Ear Infections – Amoxicillin-clavulanate can be used for certain cases of bacterial acute otitis media.
-
Bacterial Sinus Infections – May be considered when sinus infection is bacterial and this combination is clinically appropriate.
-
Lower Respiratory Infections – Can be prescribed for selected susceptible bacterial infections.
-
Other Susceptible Infections – Selection depends on the suspected or confirmed bacteria and clinical assessment.
Bottom line: MOXILASE-DUO is designed for bacterial infections, not routine viral illnesses.
Two Ingredients. One Antibacterial Strategy.
MOXILASE-DUO combines amoxycillin and potassium clavulanate to provide complementary antibacterial activity. Amoxycillin interferes with bacterial cell-wall synthesis, while clavulanate inhibits certain beta-lactamase enzymes.
How the Combination Works
-
Amoxycillin → Interferes with bacterial cell-wall formation.
-
Bacterial Control → Helps act against susceptible bacteria.
-
Clavulanate → Inhibits certain beta-lactamase enzymes.
-
Protection of Amoxicillin → Helps maintain amoxicillin activity against selected beta-lactamase-producing organisms.
-
Combined Action → Brings both components into one oral formulation.
In simple terms: one component attacks susceptible bacteria while the other helps counter certain bacterial resistance mechanisms.
Getting the Dose Right: What Matters Most?
The dosage of Amoxycillin 400mg + Potassium Clavulanate 57mg Dry Syrup is not identical for every child. The healthcare professional considers factors including body weight, infection severity, and kidney function when selecting the appropriate regimen.
Key Administration Points
-
Weight Matters – Pediatric dosing is generally determined using body weight.
-
Follow the Prescription – Use the exact quantity and frequency recommended.
-
Reconstitute Correctly – Prepare the suspension according to the product instructions.
-
Shake Before Each Dose – Shake the reconstituted suspension thoroughly.
-
Follow the Full Regimen – Do not independently stop or extend treatment.
⚠️ Dosage warning: Never change a child's antibiotic dose without consulting the prescribing healthcare professional.
Taking appropriate amoxicillin-clavulanate formulations at the start of a meal can improve clavulanate absorption and may reduce gastrointestinal intolerance.
Right prescription. Right dose. Responsible antibiotic use.
What Should You Know About Possible Side Effects?
Most reported reactions are gastrointestinal, but some reactions can be more serious. Patients should be monitored for unusual or severe symptoms during treatment.
🟢 Common: Usually Reported Reactions
|
Reaction |
What It May Feel Like |
|---|---|
|
Diarrhea |
Loose or more frequent stools |
|
Nausea |
Feeling sick or stomach discomfort |
|
Vomiting |
Episodes of vomiting |
|
Skin Rash |
Mild skin eruption in some individuals |
🔴 Serious & Rare: Don't Ignore These
|
Reaction |
Warning Signs |
|---|---|
|
Severe Allergy |
Breathing difficulty, facial swelling, or severe allergic symptoms |
|
Serious Skin Reaction |
Blistering, peeling or extensive skin involvement |
|
Liver Problems |
Yellowing of skin/eyes or dark urine |
|
Severe Diarrhea |
Persistent or significant diarrhea during or after treatment |
Safety first: Severe or rapidly worsening symptoms require prompt medical evaluation.
5 Precautions Before Using MOXILASE-DUO
-
Check Allergy History – Inform the doctor about previous penicillin or beta-lactam allergies.
-
Mention Liver Problems – Previous liver dysfunction associated with amoxicillin-clavulanate should be reported.
-
Consider Kidney Function – Renal function may influence appropriate dosing.
-
Prepare It Properly – Reconstitute the dry syrup exactly as directed.
-
Don't Share Antibiotics – Antibiotics should be used only by the person for whom they were prescribed.
A little precaution can make antibiotic treatment more responsible.
From Product to Opportunity: MOXILASE-DUO With Monark Biocare
A Product With Portfolio Potential
MOXILASE-DUO w/w Dry Syrup contains Amoxycillin 400mg + Potassium Clavulanate 57mg and comes in a 30ml glass bottle with monocarton. For pharma professionals seeking to diversify their product range, this formulation can add another prescription-based dry-syrup option to their portfolio.
Your Business. Your Market. Your Model.
With Monark Biocare, you can explore different routes to grow your pharmaceutical business:
🔹 PCD Pharma Franchise → Build your presence in selected territories
🔹 Third Party Manufacturing → Expand your range with manufacturing support
🔹 Ethical Promotion → Develop focused product promotion strategies
🔹 Export Medicines → Explore opportunities in international markets
🔹 Private Label & Contract Manufacturing → Create flexible portfolio solutions
Make the Next Move
Whether your goal is portfolio expansion, territory growth, manufacturing, ethical promotion, or pharma exports, MOXILASE-DUO can be considered as part of a broader product strategy.
Connect with Monark Biocare to explore suitable products and partnership opportunities for your business.
Disclaimer
This content is intended for general educational and product-information purposes only. MOXILASE-DUO w/w Dry Syrup should be used only under qualified medical supervision. Always follow the approved product label and healthcare professional's instructions for dosage, preparation, storage, and use.
Quick Answers About MOXILASE-DUO
01 | What is MOXILASE-DUO w/w Dry Syrup?
MOXILASE-DUO w/w Dry Syrup contains Amoxycillin 400mg + Potassium Clavulanate 57mg and is supplied as a dry powder that is reconstituted with water before oral administration.
02 | What is MOXILASE-DUO used for?
It may be prescribed for selected susceptible bacterial infections, including certain respiratory, ear and sinus infections, depending on clinical assessment.
03 | Is MOXILASE-DUO an antibiotic?
Yes. It contains amoxicillin, a penicillin-class antibacterial, combined with clavulanate, a beta-lactamase inhibitor.
04 | How should the dry syrup be prepared?
It should be reconstituted according to the product's specific instructions and shaken well before administration.
05 | Can MOXILASE-DUO treat a common cold?
No. Antibiotics do not treat viral infections, including most common colds. They should be used when a bacterial infection is diagnosed or clinically considered appropriate by a healthcare professional.
